000 01228 a2200349 4500
005 20250517182114.0
264 0 _c20171129
008 201711s 0 0 eng d
022 _a1474-1768
024 7 _a10.1038/nrc.2017.86
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVijayan, Dipti
245 0 0 _aTargeting immunosuppressive adenosine in cancer.
_h[electronic resource]
260 _bNature reviews. Cancer
_c12 2017
300 _a709-724 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aAntibodies
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
_xdrug effects
650 0 4 _aMetabolic Networks and Pathways
650 0 4 _aMice
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aPurinergic P1 Receptor Antagonists
_xtherapeutic use
650 0 4 _aTumor Microenvironment
_xgenetics
700 1 _aYoung, Arabella
700 1 _aTeng, Michele W L
700 1 _aSmyth, Mark J
773 0 _tNature reviews. Cancer
_gvol. 17
_gno. 12
_gp. 709-724
856 4 0 _uhttps://doi.org/10.1038/nrc.2017.86
_zAvailable from publisher's website
999 _c27711456
_d27711456